Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
AtriCure Stock Quote

AtriCure (NASDAQ: ATRC)

$23.45
(1.5%)
$0.35
Price as of April 17, 2024, 4:00 p.m. ET

AtriCure Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ATRC -43.72% -13.60% -2.88% +64%
S&P +20.88% +72.88% +11.56% +310%

AtriCure Company Info

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.